Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2019

Mar 27, 2019

34491_dirs_2019-03-27_d7bd1b12-efd5-4261-a875-43513ab2bbd1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-03-27

Reporting Person: Sharp Shalini (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $13.20 2028-12-04 Common Stock (147562) Direct

Footnotes

F1: The option vests as to 34% of the underlying shares on December 5, 2019 and vests in equal installments at the end of each successive three-month period over the following 24 months.